Invention Grant
- Patent Title: Oxime substituted imidazoquinolines
- Patent Title (中): 肟取代的咪唑并喹啉
-
Application No.: US10595792Application Date: 2004-11-12
-
Publication No.: US07897767B2Publication Date: 2011-03-01
- Inventor: Tushar A. Kshirsagar , Gregory D. Lundquist , David T. Amos , Joseph F. Dellaria, Jr. , Bernhard M. Zimmermann , Philip D. Heppner
- Applicant: Tushar A. Kshirsagar , Gregory D. Lundquist , David T. Amos , Joseph F. Dellaria, Jr. , Bernhard M. Zimmermann , Philip D. Heppner
- Applicant Address: US MN Saint Paul
- Assignee: 3M Innovative Properties Company
- Current Assignee: 3M Innovative Properties Company
- Current Assignee Address: US MN Saint Paul
- Agency: Wolf, Greenfield & Sacks, P.C.
- Agent C. Hunter Baker
- International Application: PCT/US2004/037854 WO 20041112
- International Announcement: WO2005/048933 WO 20050602
- Main IPC: C07D215/38
- IPC: C07D215/38

Abstract:
Imidazo ring compounds (e.g., imidazoquinolines, 6,7,8,9-tetrahydroimidazoquinolines, imidazonaphthyridines, and imidazopyridines) with an oxime substituent at the 2-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Public/Granted literature
- US20090042925A1 OXIME SUBSTITUTED IMIDAZOQUINOLINES Public/Granted day:2009-02-12
Information query